Oligonucleotide Synthesis Market By Product & Service (Synthesizer, Custom Oligonucleotide Synthesis, Probes, Premiers, Linkers & Adaptors and Reagents & Consumables), By End-User (Pharmaceutical & Biotechnology Companies, Academic Research Institutes, Diagnostic Laboratories and Others), By Application (Research, Therapeutics and Diagnostics), and By Region- Trends, Analysis and Forecast till 2030

Report Code: PMI377719 | Publish Date: April 2024 | No. of Pages: 180

Global Oligonucleotide Synthesis Market Market Companies

  • Integrated DNA Technologies, Inc. (U.S.)
  • Part of Danaher Corporation
  • Merck KGaA (Germany),
  • Eurofins Scientific SE (Luxembourg)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Agilent Technologies, Inc. (U.S.)
  • GE Healthcare (U.S.)
  • GeneDesign, Inc. (Japan) (Part of Ajinomoto Co.,Inc.)
  • Kaneka Eurogentec (Belgium) (Part of Kaneka Corporation)
  • LGC Biosearch Technologies (U.S.)
  • Bio-synthesis Inc. (U.S.)
  • TriLink BioTechnologies, LLC (U.S.)
  • Part of Maravai LifeSciences
  • ATDBio Ltd. (U.K.)

Recent News:

  • In April 2020, Microsynth AG (Switzerland) supplied primer-probe sets and other essential reagents to PCR testing labs in order to support the development and validation of precise, state-of-the-art detection techniques by molecular diagnostic companies, as well as to offer comprehensive genomics expertise to research labs investigating coronaviruses. The primary contributions are primer synthesis for NGS-based SARS-CoV-2 high-throughput diagnostics and the provision of SARS-CoV-2 detection RT-qPCR primer-probe sets.
  • In June 2020, Bio-Synthesis Inc. (US) issued cocktail mixes that were ready to use for the COVID-19 trial. These mixes included the Human RNase P (RP) Oligo Mix, the SARS-CoV-2 N2 Oligo Mix, and the SARS-CoV-2 N1 Oligo Mix.